Risk factors for neurocognitive impairment in patients with benign intracranial lesions

Stefanie Bette, Julia Ruhland, Benedikt Wiestler, Melanie Barz, Bernhard Meyer, Claus Zimmer, Yu‐Mi Ryang, Florian Ringel, Jens GemptScientific 2019 · DOI

Abstract

This study was designed to assess risk factors for neurocognitive impairment in patients with benign intracranial lesions, including tumors and vascular lesions. 74 patients (29 m, 51 f, mean age 54.4 years) undergoing surgery for benign intracranial lesions were included in this prospective single-center study. Extensive preoperative neuropsychological testing was performed, covering attention, memory, and executive functions. Additionally, headache and depression were assessed using the German versions of the HDI (IBK) and the BDI-II. Multiple linear regression analyses of percentile ranks (adjusted for age, sex, and education) were performed to identify risk factors among parameters such as age, Karnofsky Performance Status Scale (KPS), mood, pain, and lesion size. Poorer neurocognitive functions were observed primarily in the category of attention in patients with higher age and reduced KPS. Lesion volume, mood, pain, hemisphere, or lesion type (tumor vs. vascular) were not identified as significant risk factors. Age and KPS are the primary risk factors for poorer neurocognitive functions in the category of attention in patients with benign intracranial lesions.

Introduction

While neuro-oncology research frequently focuses on malignant, high-grade tumors like gliomas, benign intracranial lesions—such as meningiomas, pituitary adenomas, and vascular malformations—present a unique clinical challenge. Because these lesions typically grow slowly, the brain often exhibits significant plasticity, "rewiring" itself to compensate for the presence of the lesion. Consequently, cognitive deficits in these patients are often subtle and harder to predict than in cases of rapid-growth malignancy. This study aimed to identify which clinical factors actually correlate with preoperative neurocognitive deficits in this specific population.

Methods

This prospective, single-center study involved 74 patients with a variety of benign conditions, including meningiomas (31), pituitary adenomas (14), and various vascular lesions like cavernomas and aneurysms. To move beyond simple cognitive screenings, the researchers employed a comprehensive methodology:

  • Extensive Neuropsychological Battery: Tests included the Test of Attentional Performance (TAP), Trail-Making-Test (TMT), and Wechsler Memory Scale (WMS) to evaluate attention, memory, and executive functions.
  • Standardized Scoring: Raw test scores were converted to percentile ranks, adjusted for age, sex, and education level against normative data.
  • Volumetric Analysis: Lesion volumes were precisely calculated using semi-automatic manual segmentation of T1-weighted MRI scans.
  • Statistical Analysis: Multiple linear regression was used for metric parameters, while Mann-Whitney U tests (with Bonferroni correction) were used for nominal parameters like lesion hemisphere.

Results

The study found that the domain of attention is the most sensitive to the presence of benign lesions. Significant impairments were almost exclusively localized to this category, while memory and executive functions remained relatively stable.

Primary Risk Factors: Age and KPS

Statistical analysis identified age and functional independence (measured by the Karnofsky Performance Status Scale, or KPS) as the only significant predictors of cognitive performance. Higher age was significantly associated with poorer performance in divided attention and the WMS memory span non-verbal subtest.

Correlation between Age and WMS memory span non-verbal performance.

Similarly, higher KPS scores—indicating better overall functional status—were predictive of better performance in the WMS memory span non-verbal subtest ($P = 0.023$).

Correlation between Karnofsky Performance Status (KPS) and WMS memory span non-verbal performance.

Non-Significant Factors

Surprisingly, several factors traditionally thought to impact cognition showed no significant correlation in this cohort:

  • Lesion Volume: The physical size of the lesion (median 2.5 cm³) did not predict impairment, supporting the theory of brain plasticity in slow-growing lesions.
  • Location and Type: Neither the affected hemisphere (left vs. right) nor the type of lesion (tumor vs. vascular) significantly impacted neurocognitive scores.
  • Mood and Pain: Preoperative depression (BDI-II) and pain levels were not identified as risk factors for cognitive decline in this group.

Discussion and Conclusion

The findings suggest that for patients with benign intracranial lesions, a patient's overall functional "reserve" (KPS) and age are more reliable indicators of cognitive health than the physical characteristics of the lesion itself. The lack of correlation with lesion volume highlights the brain's remarkable ability to compensate for slow-growing obstacles.

Clinically, these results emphasize that attention is the "canary in the coal mine" for these patients. Understanding that age and KPS are the primary drivers of impairment can help clinicians better manage patient expectations and tailor rehabilitation strategies. Future research should focus on larger, more homogenous cohorts and track post-operative recovery to determine if surgical intervention successfully restores these specific attentional functions.

Summary updated

Abstract

This study was designed to assess risk factors for neurocognitive impairment in patients with benign intracranial lesions including tumors and vascular lesions. 74 patients (29 m, 51 f, mean age 54.4 years) with surgery for benign intracranial lesions were included in this prospective single-center study. Extensive neuropsychological testing was performed preoperatively, including tests for attention, memory and executive functions. Furthermore, headache and depression were assessed using the german version of the HDI (IBK) and the BDI-II. Multiple linear regression analyses of the percentile ranks (adjusted for age, sex and education) including the parameters age, Karnofsky Performance Status Scale (KPS), mood, pain and lesion size were performed to identify risk factors for cognitive impairment. Using the Mann-Whitney U test, the influence of hemisphere and type of lesion (tumor/vascular) was assessed. Posthoc Bonferroni correction was performed. Poorer neurocognitive functions were observed only in the category attention in patients with higher age (divided attention, WMS) and reduced KPS (WMS). Lesion volume, mood, pain, hemisphere or the type of the lesion (tumor, vascular) were not identified as risk factors for poorer neurocognitive functions in patients with benign intracranial lesions. Age and KPS are the main risk factors for poorer neurocognitive functions in the category attention in patients with benign intracranial lesions. Knowledge of these risk factors might be important to find appropriate therapy regimes to improve cognitive functions and quality of life.
BibTeX
@inproceedings{bette2019risk,
  author = {Stefanie Bette and Julia Ruhland and Benedikt Wiestler and Melanie Barz and Bernhard Meyer and Claus Zimmer and Yu‐Mi Ryang and Florian Ringel and Jens Gempt},
  title = {{Risk factors for neurocognitive impairment in patients with benign intracranial lesions}},
  booktitle = {Scientific},
  year = {2019},
  doi = {10.1038/s41598-019-44466-y},
}
Figure